Posts

Discovering a New ‘Shy’ Fungal Species Hidden in Old-Gr...

New Discoveries in the Fungal Kingdom: Five New Species of Piloderma Unveiled In...

EC approves Bristol Myers Squibb’s follicular lymphoma ...

The EC has granted expanded approval to BMS' Breyanzi, to treat adults with rela...

Projected Doubling of Cardiovascular Disease Burden Due...

The impact of extreme heat on public health is becoming increasingly evident, es...

Revolutionary Advancement in Green Hydrogen Peroxide Pr...

Hydrogen peroxide is one of the most valuable industrial chemicals globally, ren...

Enhancing Public Accessibility of Naloxone Kits: A Life...

A recent study published in the Canadian Medical Association Journal emphasizes ...

Empowering New Nurses: Essential Learning Resources for...

In the demanding and fast-paced environment of healthcare, the transition from t...

Study Reveals No Elevated Mortality or Admission Dispar...

Recent research published in the Canadian Medical Association Journal has produc...

Consistent Medication Use Crucial for Heart Failure Man...

Patients with heart failure who have shown signs of recovery in heart pump funct...

Study Finds Increased Childhood Cancer Risk in Newborns...

A recent study has unveiled a concerning correlation between congenital heart de...

Revolutionary Approaches to Amplify Chiral Optical Sign...

In the intricate world of molecular science, chiral molecules exhibit a fascinat...

Unveiling Revolutionary Research at the 2025 Gut Microb...

Bethesda, MD (March 12, 2025) — The upcoming 13th Gut Microbiota for Health Worl...

AstraZeneca director says AI must be a “thought partner...

AstraZeneca’s senior director in oncology data science outlined how the company ...

Boehringer Ingelheim and Salipro enter drug discovery p...

Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research an...

MeiraGTx and Hologen launch AI-backed gene therapy venture

The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase II...

EC approves Otsuka and Lundbeck’s Rxulti for schizophrenia

The EC has approved Otsuka Pharmaceutical and Lundbeck’s atypical oral antipsych...

Insilico raises $110m to develop drug pipeline and AI p...

Insilico Medicine has completed a Series E round, raising $110m to progress the ...